Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report)’s stock price fell 1.5% during trading on Tuesday . The company traded as low as $9.27 and last traded at $9.27. Approximately 1,000 shares traded hands during trading, a decline of 28% from the average session volume of 1,382 shares. The stock had previously closed at $9.41.
Sumitomo Pharma Stock Performance
The firm has a 50 day moving average price of $8.80 and a two-hundred day moving average price of $11.06.
About Sumitomo Pharma
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
Further Reading
- Five stocks we like better than Sumitomo Pharma
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
